Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma

Published:2021-03 Issue:3 Volume:101 Page:194-201
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Jimura Nozomi,Fujii Kazuyasu,Qiao Zhiwei,Tsuchiya Ryuto,Yoshimatsu Yuki,Kondo Tadashi,Kanekura Takuro

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference50 articles.

1. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL);Duvic;Blood,2007

2. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma;Olsen;J. Clin. Oncol.,2007

3. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma;Piekarz;J. Clin. Oncol.,2009

4. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma;Whittaker;J. Clin. Oncol.,2010

5. Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition;Dummer;Leuk. Lymphoma,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities;Bioorganic Chemistry;2024-01

2. Ponatinib: An update on its drug targets, therapeutic potential and safety;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09

3. DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro;Frontiers in Genetics;2022-11-08

4. Functional Depletion of HSP72 by siRNA and Quercetin Enhances Vorinostat-Induced Apoptosis in an HSP72-Overexpressing Cutaneous T-Cell Lymphoma Cell Line, Hut78;International Journal of Molecular Sciences;2021-10-19